leadf
logo-loader
NYSE:ATNM

Actinium Pharmaceuticals Inc

Receive alerts
Market:
NYSE
Market Cap:
$136.14 m
Price
10.02 USD
Change
-2.58%
52 weeks high
19.44
52 weeks low
4.77

In brief

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.